2004
DOI: 10.1097/01.rvi.0000133505.84588.8c
|View full text |Cite
|
Sign up to set email alerts
|

N-Butyl Cyanoacrylate Embolization for Control of Acute Arterial Hemorrhage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
68
0
6

Year Published

2006
2006
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 135 publications
(78 citation statements)
references
References 22 publications
4
68
0
6
Order By: Relevance
“…In previous papers, several embolic devices were deployed in the proximal [10,102,105] or distal vessels [79,101] of the target lesion to reduce blood flow through the lesion and prevent the injected NBCA from migrating. In addition, other studies have described various combination methods in which the target lesion was embolized with NBCA through the main feeding artery after embolic devices such as metallic coils had been deployed in numerous small feeding arteries or draining veins, or in which multiple tiny feeding arteries were occluded with particles after the majority of the target lesion had been embolized with NBCA [20,58,81,128].…”
Section: Specific Statementmentioning
confidence: 99%
See 1 more Smart Citation
“…In previous papers, several embolic devices were deployed in the proximal [10,102,105] or distal vessels [79,101] of the target lesion to reduce blood flow through the lesion and prevent the injected NBCA from migrating. In addition, other studies have described various combination methods in which the target lesion was embolized with NBCA through the main feeding artery after embolic devices such as metallic coils had been deployed in numerous small feeding arteries or draining veins, or in which multiple tiny feeding arteries were occluded with particles after the majority of the target lesion had been embolized with NBCA [20,58,81,128].…”
Section: Specific Statementmentioning
confidence: 99%
“…In the thoracoabdominal field, embolic devices are often deployed in the distal portion of the target lesion to prevent the distal migration of NBCA [19,34,72,108,109,149,163], and NBCA is sometimes used in combination with other embolic materials in cases in which the target lesion was insufficiently embolized [72,77,81,87,134,162,180,182]. NBCA has also been occasionally used to fix the tips of indwelling catheters in place during hepatic arterial infusion chemotherapy [173,181].…”
Section: Specific Statementmentioning
confidence: 99%
“…11 Immediate and late follow-up examinations of our patient did not show any clinical signs or symptoms of complications of maxillary artery embolization.…”
Section: Discussionmentioning
confidence: 48%
“…To reduce the risk of type II endoleaks in elective EVAR, previous reports demonstrated intrasac ''thrombization'' using fibrin glue injection with or without the insertion of coils [6,7]. However, because patients with r-AAA frequently also have severe coagulation abnormalities, NBCA seems to be a more feasible embolic material [8,9]. In addition, a previous report described successful glue embolization of an r-AAA by a late type I endoleak after EVAR [10].…”
Section: Discussionmentioning
confidence: 99%